Topical therapy with a paromomycin-based cream offered an effective treatment for cutaneous leishmaniasis.
Gradually increasing intensity of treatment reduces alcohol intake and improves HIV status
A total of 26 RCTs with 8136 patients were included in this network meta analysis.
Among children under age 5 years with acute gastroenteritis, Lactobacillus reuteri DSM 17938 as an adjunct to rehydration therapy did not reduce the duration of diarrhea compared with placebo.
Ceftriaxone remains the superior first-line treatment for gonorrhea compared with gentamicin.
Investigators sought to determine whether the use of ivermectin in patients with scabies leads to improved clinical and safety outcomes compared with permethrin.
Oral voriconazole may be more effective than oral itraconazole for initial maintenance therapy in patients with chronic pulmonary aspergillosis, according to a study published in Clinical Infectious Diseases.1 Currently, there are 4 oral anti-Aspergillus agents available (itraconazole, voriconazole, posaconazole, and isavuconazole) and while various studies have evaluated treatments for chronic pulmonary aspergillosis with itraconazole and…
Serious infections related to treatment with rituximab in patients with multiple sclerosis are rare and successfully resolvable.
More than one-third of respondents reported no administrative methods for responding to shortages.
Investigators evaluated the real-life efficacy of pegylated interferon α-2b with ribavirin in treatment-naive patients with chronic genotypes 2 or 3 hepatitis C virus infection.
Replacing ethambutol with moxifloxacin has not shown efficacy in tuberculosis treatment success in an 8-week trial.
Adhering to mucormycosis treatment guidelines may be difficult for physicians because of the complexity of the disease.
Continuous infusion of vancomycin, compared with intermittent infusions, was linked to earlier and improved attainment of target concentrations in infants.
Dolutegravir monotherapy was noninferior to combination antiretroviral therapy (cART) in patients who started cART during primary HIV infection.
Compared with placebo, single-dose tafenoquine significantly lowered risk for Plasmodium vivax malaria relapse at 6 months.
Practices vary among clinicians in diagnosing and managing Staphylococcus aureus bacteremia in adults.
The FDA has granted Breakthrough Therapy designation to CP101 for the treatment of patients with recurrent Clostridium difficile.
The risk for stroke is significantly increased after the appearance of shingles, despite adequate antiviral therapy and administration of the shingles vaccine.
Sofosbuvir-velpatasvir administered for 12 weeks is efficacious and safe for Asian patients with chronic HCV.
More patients with HIV who were not recommended for statin therapy experienced cardiovascular disease events compared with a control group.